Detailed price information for Maia Biotechnology Inc (MAIA-A) from The Globe and Mail including charting and trades.
Brian Tait calls for public support to fund exciting groundbreaking technology for assigning phase to multiple mutations ...
More than 60 years after its discovery, scientists are still learning surprising ways DNA stores and translates instructions ...
The fat-tailed dunnart is native to Australia's arid scrublands and largely unknown outside of science. It may also be the ...
Researchers have uncovered epigenetic signatures behind persistent cellular memories of inflammation, which can drive chronic ...
Strong participation in recent $33 million common stock offering highlights investor confidence in late-stage clinical momentum and commercial potential Statistical assessments point to high probabili ...
A wave of AI foundation models built on plant DNA sequences is giving researchers new tools to annotate genomes, predict gene ...
One of the most puzzling aspects of common chronic inflammatory skin diseases such as psoriasis is how they become chronic.
Attorneys for Florida death row inmate James Aren Duckett filed an emergency motion with the Florida Supreme Court late ...
MGnify Genomes offers new ways to explore microbial communities in soil, marine sediments, and the gut Microbial communities ...
Attachment to smart devices and biometric surveillance leaves Americans more vulnerable to police searches than ever. Left unchecked it will only get worse.
Potential breakthrough therapeutic targets $50B+ global immunotherapy market1CHICAGO, March 31, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, ...